Urine heart failure risk score fell within the supplement group
A small randomized study in adults with diabetes found a lower urine-based risk score in the supplement group, without establishing a reduction in actual heart failure.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In within-group analyses, the supplement group’s urine score linked to future heart failure risk fell. Changes in coronary artery disease and chronic kidney disease scores were not detected; neither were score changes in the diet or placebo groups. These results do not establish fewer heart failure events or superiority over placebo.
The reported tests compared each group with its own baseline. The abstract provides no direct between-group effect estimate and reports risk scores rather than clinical events.
What researchers found
Urinary heart failure risk score
Supplement group at 12 weeks versus its own baseline; mean score change, 95% CI -0.83 to -0.33. The endpoint was a urine biomarker.
What the test measured
Researchers analyzed patterns of peptide fragments in urine and used classifiers associated with future disease risk. The abstract reports molecular signals and does not establish whether participants later developed the diseases.
Why the comparison matters
A change within the supplement group answers a different question from a direct comparison with placebo. The abstract’s statistical approach leaves uncertainty about whether the groups’ changes differed from each other.
The original publication
Dietary glycocalyx mimetic reduces vascular risk in Type 2 diabetes: evidence from urinary peptidomic classifiers in a South-Asian Surinamese Cohort.
Biglari S, Yuan L, Mischak H et al.
Diabetes Res Clin Pract · 2025
- PubMed ID
- 41052726
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.